ACh, short for acetylcholine, is the body’s most widespread neurotransmitter, a chemical messenger that carries signals between nerve cells and from nerves to muscles and organs. It operates across nearly every major system in the body: triggering muscle contractions, regulating heart rate, supporting memory, and coordinating the autonomic nervous system that controls unconscious functions like digestion and sweating. Understanding where ACh works and how it moves through the body’s anatomy is foundational to understanding how the nervous system communicates.
How ACh Is Made and Stored
ACh is built from two simple ingredients: choline (a nutrient found in foods like eggs and liver) and a fragment derived from glucose metabolism called an acetyl group. A specialized enzyme inside nerve endings fuses these two components together, producing a single ACh molecule with the chemical formula C₇H₁₆NO₂ and a molecular weight of about 146. The molecule carries a positive electrical charge, which is key to how it interacts with receptors on target cells.
Once assembled, ACh molecules are packed into tiny bubble-like containers called vesicles that sit near the tip of the nerve ending. Each vesicle holds thousands of ACh molecules, ready for rapid release. When an electrical signal travels down the nerve and reaches the terminal, calcium rushes in and triggers these vesicles to fuse with the nerve’s outer membrane, dumping their ACh into the gap between the nerve and its target.
The Neuromuscular Junction
The most well-studied site of ACh activity is the neuromuscular junction, the point where a motor nerve meets a skeletal muscle fiber. This junction has three distinct layers: the presynaptic terminal (the nerve ending), the synaptic cleft (the gap), and the postsynaptic membrane (the muscle surface).
The nerve terminal sits in a shallow groove on the muscle fiber called a primary cleft. Between the nerve and muscle is the synaptic cleft, a narrow gap filled with a specialized scaffolding of proteins, including laminins and collagens, that keeps the junction properly aligned. When ACh is released from the nerve terminal, it crosses this gap and binds to receptors clustered on the muscle surface. These receptors are concentrated at the tops of deep folds in the muscle membrane, a design that maximizes the area available for signal reception. Binding triggers an electrical change in the muscle that initiates contraction.
Attached to the scaffolding within the synaptic cleft is an enzyme called acetylcholinesterase, which breaks down ACh almost instantly after it has done its job. This enzyme works at an extraordinarily fast rate, processing ACh at speeds exceeding 100 million molecular reactions per second. That rapid cleanup is what allows muscles to contract and relax in quick, precise bursts rather than staying locked in contraction.
ACh in the Autonomic Nervous System
Beyond skeletal muscles, ACh is the primary signaling molecule in both branches of the autonomic nervous system, the network that controls involuntary body functions. In the parasympathetic branch (the “rest and digest” system), ACh handles virtually all communication. It is the neurotransmitter used by preganglionic neurons leaving the brain and spinal cord, and it is also used by the postganglionic neurons that directly contact organs like the heart, lungs, stomach, and intestines.
In the sympathetic branch (the “fight or flight” system), ACh plays a more limited but still essential role. It serves as the neurotransmitter for all preganglionic sympathetic neurons, carrying signals from the spinal cord to relay stations called ganglia. From there, most postganglionic sympathetic neurons switch to a different neurotransmitter, norepinephrine, to reach their target organs. Two notable exceptions exist: sweat glands and the tiny muscles that make your hair stand on end (piloerector muscles) are innervated by sympathetic neurons that continue to use ACh all the way to the target.
ACh also acts as the neurotransmitter at the adrenal medulla, the inner portion of the adrenal glands sitting on top of your kidneys. When ACh signals reach the adrenal medulla, it triggers the release of adrenaline and noradrenaline into the bloodstream, producing the body-wide surge of energy associated with acute stress.
Cholinergic Pathways in the Brain
Inside the brain, ACh-producing neurons are organized into distinct clusters that project to widespread regions. The forebrain cholinergic system is the most prominent, consisting of several groups of neurons (labeled Ch1 through Ch8 by researchers) that send fibers to the cerebral cortex and the hippocampus, a region critical for forming new memories. One particularly important cluster is the nucleus basalis, which supplies ACh to nearly the entire outer surface of the brain. This nucleus plays a role in maintaining consciousness, supporting learning, and coordinating voluntary movement.
A separate group of cholinergic neurons in the brainstem projects to the thalamus (the brain’s sensory relay hub), the hypothalamus (which regulates hormones, hunger, and body temperature), and back to the forebrain cholinergic nuclei themselves. Additionally, the caudate nucleus and putamen, deep brain structures involved in movement planning, contain their own population of large cholinergic interneurons that modulate local circuits rather than sending long-range projections.
This architecture means ACh doesn’t just relay simple signals in the brain. It acts more like a volume dial, adjusting how alert, attentive, and receptive the cortex is to incoming information.
Two Types of ACh Receptors
ACh exerts different effects depending on which type of receptor it activates, and the body has two fundamentally different kinds.
- Nicotinic receptors are channel-shaped proteins embedded in cell membranes that open when ACh binds to them, allowing sodium ions to rush in and generate a rapid electrical signal. They are found at skeletal neuromuscular junctions, in autonomic ganglia (both sympathetic and parasympathetic), and throughout the central nervous system. These receptors produce fast, excitatory responses.
- Muscarinic receptors work through a slower, indirect signaling process. Rather than opening a channel directly, they trigger a cascade of chemical events inside the cell. These receptors are found on smooth muscle (in the gut, airways, and blood vessels), cardiac muscle, and glands. They are responsible for the parasympathetic effects of ACh: slowing heart rate, stimulating digestion, constricting the pupils, and increasing glandular secretions.
This two-receptor system explains how a single molecule can make your skeletal muscles contract forcefully while simultaneously slowing your heart. The outcome depends entirely on which receptor type is present at a given anatomical site.
What Happens When ACh Signaling Breaks Down
Because ACh operates in so many systems, disruptions can have wide-ranging consequences. One of the clearest examples is myasthenia gravis, an autoimmune condition in which the body produces antibodies that attack nicotinic receptors at the neuromuscular junction. These antibodies cause damage through three overlapping mechanisms: they activate a destructive immune cascade that physically tears apart the folded postsynaptic membrane, they cause receptors to be pulled inside the muscle cell and degraded faster than normal, and in some cases they directly block the ACh binding site on the receptor.
The result is progressive muscle weakness, because fewer functional receptors remain available to receive ACh signals. The destruction of the postsynaptic folds also increases the physical distance between the nerve terminal and the remaining receptors, further weakening signal transmission. This is why people with myasthenia gravis often experience drooping eyelids, difficulty swallowing, and fatigue that worsens with repeated muscle use.
In the brain, the degeneration of cholinergic neurons in the nucleus basalis is one of the hallmarks of Alzheimer’s disease. The loss of ACh input to the cortex and hippocampus contributes to the memory impairment and cognitive decline that characterize the condition, which is why some treatments aim to slow the breakdown of whatever ACh remains in the brain by inhibiting the enzyme that degrades it.